Putative conventional protein kinase C inhibitor Gödecke 6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] stimulates transglutaminase activity in primary mouse epidermal keratinocytes
- PMID: 12065737
- DOI: 10.1124/jpet.302.1.352
Putative conventional protein kinase C inhibitor Gödecke 6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] stimulates transglutaminase activity in primary mouse epidermal keratinocytes
Abstract
Much data in the literature suggest a role for protein kinase C (PKC) in regulating keratinocyte proliferation and differentiation. Nevertheless, the exact role of this family of isoenzymes is unclear, since PKC agonists (e.g., phorbol esters) are known to stimulate expression of both proliferative and differentiative markers in keratinocytes. Similarly, PKC inhibitors have been demonstrated both to inhibit [2-[1-3(aminopropyl)indol-3-yl]-3(1-methyl-1H-indol-3-yl)maleimide, acetate (Ro 31-7549) and 3-[1-[3-(amidinothio)propyl-1H-indol-3-(1-methyl-1H-indol-3yl) maleimide (Ro 31-8220)] and to induce (staurosporine) keratinocyte differentiation. In this study, we examined the role of the PKC inhibitor, Gödecke 6976 (Gö6976) [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo (3,4-c)-carbazole], on keratinocyte proliferation, as measured by DNA synthesis, and differentiation, as monitored by transglutaminase activity. This compound is reported to be selective for the conventional PKC isoforms, of which keratinocytes express only PKCalpha, and for protein kinase D (PKD; also known as PKCmu). We report that Gö6976 stimulated transglutaminase activity. Consistent with this effect, Gö6976 also potently inhibited [(3)H]thymidine incorporation (a half-maximal inhibitory concentration of approximately 0.1 microM). In addition, Gö6976 (1 microM) was able to enhance the stimulation of transglutaminase activity by 1,25-dihydroxyvitamin D(3) but had no effect on D(3)-induced expression of keratin-1. Conversely, Gö6983 [2-[1-(3-dimethylaminopropy)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl)maleimide], a similar compound that also selectively inhibits conventional PKCalpha, but not PKD, had little or no effect on DNA synthesis or transglutaminase activity (up to 1 microM). The effect of Gö6976 was not due to cytotoxicity as its effect on thymidine incorporation was largely reversible, and its stimulation of transglutaminase activity could be inhibited by another general PKC inhibitor, bisindolylmaleimide I. Therefore, our results suggest a proproliferative, antidifferentiative role for PKD in epidermal maturation.
Similar articles
-
The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors.J Dermatol Sci. 2010 Oct;60(1):29-39. doi: 10.1016/j.jdermsci.2010.07.015. Epub 2010 Aug 10. J Dermatol Sci. 2010. PMID: 20832999 Free PMC article.
-
The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.Mol Pharmacol. 2005 Jan;67(1):184-94. doi: 10.1124/mol.104.003533. Epub 2004 Oct 1. Mol Pharmacol. 2005. PMID: 15465928
-
Protein kinase C-independent effects of protein kinase D3 in glucose transport in L6 myotubes.Mol Pharmacol. 2005 Jan;67(1):152-62. doi: 10.1124/mol.104.004200. Epub 2004 Oct 20. Mol Pharmacol. 2005. PMID: 15496505
-
Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene.Mol Pharmacol. 1998 Apr;53(4):630-7. doi: 10.1124/mol.53.4.630. Mol Pharmacol. 1998. PMID: 9547352
-
Protein kinase D and keratinocyte proliferation.Drug News Perspect. 2004 Mar;17(2):117-26. doi: 10.1358/dnp.2004.17.2.829045. Drug News Perspect. 2004. PMID: 15098066 Review.
Cited by
-
A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.Cancer Res. 2009 Jan 1;69(1):65-74. doi: 10.1158/0008-5472.CAN-08-0377. Cancer Res. 2009. PMID: 19117988 Free PMC article.
-
Protein kinase D1 deficiency promotes differentiation in epidermal keratinocytes.J Dermatol Sci. 2014 Dec;76(3):186-95. doi: 10.1016/j.jdermsci.2014.09.007. Epub 2014 Oct 2. J Dermatol Sci. 2014. PMID: 25450094 Free PMC article.
-
PKCdelta-mediated regulation of FLIP expression in human colon cancer cells.Int J Cancer. 2006 Jan 15;118(2):326-34. doi: 10.1002/ijc.21373. Int J Cancer. 2006. PMID: 16052516 Free PMC article.
-
Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis.Sci Rep. 2016 Aug 26;6:32083. doi: 10.1038/srep32083. Sci Rep. 2016. PMID: 27561392 Free PMC article.
-
The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors.J Dermatol Sci. 2010 Oct;60(1):29-39. doi: 10.1016/j.jdermsci.2010.07.015. Epub 2010 Aug 10. J Dermatol Sci. 2010. PMID: 20832999 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials